8- The Michigan Daily - SPORTSMonday - Monday, February 28, 1994 HERRINGTON Continued from page 3 the fact that CBS wanted to show the "good stuff' in prime time, Turner's cable channel was forced to cut to commercials whenever anyone expected to finish higher than 10th was performing. So rather than show half-day old events, TNT showed one and a half-day old events. I guess if the competition at the Games had at least been any good, it might have made up for all of television's shortcomings. Yet aside from Dan Jansen finally winning a gold medal, even the American competitors were pretty boring. Just because your name is Picabo doesn't make you the next Mary Lou Retton. By the end of the Games I was once again longing for the links. Sadly, the Winter Olympics seemed to make this one of the most boring breaks I've ever had, even for Connecticut standards. I thought it couldn't get much worse than last year when I had my wisdom teeth pulled, but wonders never cease. Except in Lillehammer. Rawlinson Photography Presents:M $1.00 A Bridal Faire Wednesday, March 2, 1994 6:00 P.M. At the The Mayflower Meeting House - 455 South Main Street -;Plymouth, MI 48170 " . Tickets are $3.00 in advance $4.00 at the door / * Fashion Show \ " Exhibits " Prizes. . Free Engagement po.ra.t of all Wedding Couples in Attendance-. Call for Ticket information: 453-8872_ oSU Continued from page 4 erts said. "For some reason she has found her niche. That is the kind of performance we need. We need her to be a leader and to put up numbers like that." Wolverine point guard Jennifer Kiefer also came through. She made all five of her shots, including three treys, while collecting three assists and three steals. "She's done a great job," Ohio State point guard Alysiah Bond said. "She is very poised, very confident. She did all the things she supposed to do to help her team." But while the two guards matched Smith in points, they could not equal the Buckeyes' ability to draw the foul. Smith went to the free-throw line 15 times with her aggressive movement to the hole - putting center Jennifer Brzezinski and forward Silver Shellman to the bench early with foul trouble. "Today the ref actually called some fouls," Smith said. "That helps when they get in foul trouble. You can be more aggressive when they do call." A favorable call for Smith proved to be one of the turning points of the contest. After a Johnson bucket cut the Buckeyes lead to 59-56 at 6:47 of the second half, Smith drew a block- ing foul on freshman Jennifer Kiefer while tossing in a sprawling jumper. Smith converted the three-point play for a 62-56 lead and Michigan never came closer. "They were protecting Katie Smith all night long," Roberts said. "I think this game was taken away from us. It took three not so good officials and 12,000 fans to do it. We don't get any respect at all in the Big Ten." By BRENT McINTOSH DAILY BASKETBALL WRITER Isn't setting records supposed to be satisfying? Isn't it supposed to be fulfilling? Well, the Michigan women's bas- ketball team has set several records this -year thanks to much-improved three-point shooting, but coach Trish Roberts isn't exactly happy about it. The Wolverines have made more three-pointers (94) this season than any other season. They have also set the Michigan single-game record for threes attempted by a team (20), made by a team (nine), attempted by an individual (10 by freshman guard Amy Johnson), and made by an indi- vidual (five by freshman guard Jen- nifer Kiefer). Along the way, Kiefer has grabbed the distinction of being Michigan's most accurate three-point shooter ever, at .452, and Johnson is already third on the list for career three-point- ers made at 43, despite being a rookie. These are impressive stats, but Roberts would trade them all for some solid post play. "Right now our perimeter players are a little more confident and our inside game is not that strong," Rob- erts said. "We traditionally don't post up very strong inside - we really don't have an inside game, so our outside players feel a little more con- fident. "Most times when they pass the ball inside, they get turnovers. They don't have confidence in (the team's) inside game. You'll notice that a lot of our offense is geared towards the jump shots." THAT COLUMBUS MYSTIQUE: The Wolverines managed' once again to lose in St. John Arena, this time 80- 73, February 20, keeping the number of Michigan women's basketball vic- tories in that venue at zero. The hostile crowd they faced in Columbus numbered 12,003 - the largest crowd before which any Wol- verine women's hoop squad has ever played. MICHIGAN VS. IOWA, IOWA vS. THE WORLD: Michigan's 65-55 loss yes- terday marked its 17th consecutive loss to Iowa. The Wolverines haven't triumphed since a 58-56 victory Janu- ary 19, 1986 - when current fresh- man guards Kiefer and Mekisha Ross were 10 years old. Despite sweeping Michigan, the Hawkeyes have lost five times this year and dropped to No. 14 in the AP poll. This is the first time since the 1990-91 season that coach Vivian Stringer's team hasn't been in the top ten. "We've been struggling all year," Stringer said. "We've been up and down. We've played good in games against big people, and we struggle, as a rule, against lesser opponents. It's been a struggle." A RAINBOW OF SOCKs: The Wol- verines have recently broken out blue socks, a fashion statement in contrast to the white they had worn earlier in the season. Iowa's players wore mostly white socks, but a couple of players, including Hawkeye star Necole Tunsil, showed up in black socks, a la Michigan's Fab Five. BASKETBALL NOTEBOOK: Roberts finds record- setting ungratfying IOWA Continued from page 4 gan lost by only nine points in its first meeting with the Gophers (7-6,16-6), Jan. 30. "Last week we really expected that we could do a better job against Minnesota," Michigan assistantcoach Kathy LaBarge Miles said. "Up there we lost by nine and we felt that we played a terrible game." Ten minutes into the game, Min- nesota lead 16-6. Two Michigan timeouts failed to ignite the players, who trailed 39-21 at the half. "For some reason we weren't re- ally ready to play," LaBarge Miles said. "We played like seven individu- als. Not that anybody was trying to do it all themselves, but just that nobody really seemed to be in synch with each other." The Gophers played an intense first half, during which they snatched 14 of their 21 steals. "We forced a lot of turnovers in the first half with our pressure," Min- nesota coach Linda Hill-MacDonald said. "(Michigan) was rushing its passes a little bit." Like Iowa, almost all of Minnesota's players contributed to the scoring. Shudlick, who ranks third in the country in scoring, led Minne- sota with 25 points. Pearson and Loeblein each had 18. "This is not a selfish team, not in the least," Hill-MacDonald said. "They don't care who does the scor- ing; what matters is what the scoreboard says in the end." For the Wolverines, Johnson had another big night, bringing in 25 points. In spite of another disappointing weekend for Michigan women's bas- ketball, the team remains upbeat. "We're looking at it like this: we've got four games left. Our record is 0-0," said team captian Shimmy Gray. "We want to be 4-0 at the end of the season. That's how we're looking at it." " 0 The University Unions need YOU to participate in Focus Groups regarding Meeting Room & Food Service/Catering. Policies U 3 Department of Recreational Sports INTRAMURAL SPORTS PROGRAM North Campus Commons in the Boulevard Room Thursday, March 3 2pm - 3pm Wednesday, March 9 6pm - 7pm MOSCOW ST. PETERSBURG MOSCOW INTERNATIONAL PROGRAMS BOSTON'b UNIVERSITY Egz Michigan League Tuesday, March 1 10am -11am in Room D, third floor Thursday, March 3 6pm - 7pm Michigan Union in the Welker Room Friday, March 4 2pm - 3pm Monday, March 7 6pm - 7pm Tuesday, March 8 10am - 11am MINI-SOCCER Entries Taken: Tuesday 3/1 (Instant Scheduling) 11:00 a.m. - 4:30 p.m. IMSB Main Lobby Play Begins: Thursday 3/3 For Additional Information Contact IMSB 763-3562 3 0 The Moscow Internship Program Experience Russia Firsthand For program details complete the coupon below and mail it to: Boston University International Programs 232 Bay State Road, Box R, Boston, MA 02215 - 617/353-9888 An equal opporunity affim"rive action in"tit"tion Each Focus Group is limited to 10 participants. Please call 764-0446 to reserve your spot. 0 0 rj I Contraceptive Injection (sterile medroxyprogesterone acetate suspension, USP) WHAT IS DEPO-PROVERA CONTRACEPTIVE INJECTION? DEPO-PROVERA Contraceptive Injection is a form of birth control that is given as an intra- muscular injection (a shot) in the buttock or upper arm once every 3 months. To continue your contraceptive protection, you must return for your next injection promptly at the end of 3 months. DEPO-PROVERA contains medroxyprogesterone acetate, a chemical similar to (but not the same as) the natural hormone progesterone, which is produced by your ovaries during the second half of your menstrual cycle. DEPO-PROVERA acts by preventing your egg cells from ripening. If an egg is not released from the ovaries during your menstrual cycle, it cannot become fertilized by sperm and result in pregnancy. DEPO-PROVERA also causes changes in the lining of your uterus that make it less likely for pregnancy to occur. HOW EFFECTIVE IS DEPO-PROVERA CONTRACEPTIVE INJECTION? DEPO-PROVERA is over 99% effective, making it one of the most reliable methods of birth control available. This means that the average annual pregnancy rate is less than one for every 100 women who use DEPO-PROVE RA. The effectiveness of most contraceptive methods depends in part on how reliably each woman uses the method. The effectiveness of DEPO-PROVERA depends only on the patient returning every 3 months for her next injection. Your health-care provider will help you compare DEPO-PROVERA with other con- traceptive methods and give you the information you need in order to decide which contra- ceptive method is the right choice for you. The following table shows the percent of women who got pregnant while using different kinds of contraceptive methods. It gives both the lowest expected rate of pregancy (the rate expected in women who use each method exactly as it should be used) and the typical rate of pregnancy (which includes women who became pregnant because they forgot to use their birth control or because they did not follow the directions exactly). PERCENT OF WOMEN EXPERIENCING AN ACCIDENTAL PREGNANCY IN THE FIRST YEAR OF CONTINUOUS USE Lowest Method Expected Typical DEPO-PROVERA 0.3 0.3 Implants (Norplant") 0.3 0.3 Female sterilization 0.2 0.4 Male sterilization 0.1 0.15 Oral contraceptive (pill) 3 Combined 0.1- Progestogen only 0.5 - IUD 3 Progestasert 2.0-- Copper T 380A 0.8- Condom (without spermicide) 2 12 Diaphragm (with spermicide) 6 18 Cervical Cap 6 18 Withdrawal 4 18 Periodic abstinence 1 - 9 20 Spermicide alone 3 21 Vaginal Sponge Used before childbirth 6 18 Used after childbirth 9 28 No method 85 85 Source: Trussell et al; Obstet Gyncol 76:558, 1990 occur and, therefore, the bleeding that comes with your normal menstruation does not take place. When you stop using DEPO-PROVERA your menstrual period will usually, in time, return to its normal cycle. 2. Bone Mineral Changes Use of DEPO-PROVERA may be associated with a decrease in the amount of mineral stored in your bones. This could increase your risk of developing bone fractures. The rate of bone mineral loss is greatest in the early years of DEPO-PROVERA use, but after that, it begins to resemble the normal rate of age-related bone mineral loss. 3. Cancer Studies of women who have used different forms of contraception found that women who used DEPO-PROVERA for contraception had no increasedoverall risk of developing cancer of the breast, ovary, uterus, cervix, or liver. However, women under 35 years of age whose first exposure to DEPO-PROVERA was within the previous 4 years may have a slightly increased risk of developing breast cancer similar to that seen with oral contraceptives. You should discuss this with your health-care provider. 4. Accidental Pregnancy Because DEPO-PROVERA is such an effective contraceptive method, the risk of accidental pregnancy for women who get their shots regularly (every 3 months) is very low. While there have been reports of an increased risk of low birth weight and neonatal infant death or other health problems in infants conceived close to the time of injection, such pregnancies are rare. If you think you may have become pregnant while using DEPO-PROVERA for con- traception, see your health-care provider as soon as possible. 5. Other Risks Women who use hormone-based contraceptives may have an increased risk of blood clots or stroke. Also, if a contraceptive method fails, there is a possibility that the fertilized egg will begin to develop outside of the uterus (ectopic pregnancy). While these events are rare, youtshould tell your health-care provider if you have any of the problems listed in the next section. WHAT SYMPTOMS MAY SIGNAL PROBLEMS WHILE USING DEPO-POVERA CONTRACEPTIVE INJECTION? Call your health-care provider immediately if any of these problems occur following an injection of DEPO-PROVERA: Sharp chest pain, coughing of blood, or sudden shortness of breath (indicating a possible clot in the lung); sudden severe headache or vomiting, dizzi- ness or fainting, problems with your eyesight or speech, weakness, or numbness in an arm or leg (indicating a possible stroke); severe pain or swelling in the calf (indicating a possible clot in the leg); unusually heavy vaginal bleeding; severe pain or tenderness in the lower abdominai area; or persistent pain, pus, or bleeding at the injection site. WHAT ARE THE POSSIBLE SIDE EFFECTS OF DEPO-PROVERA CONTRACEPTIVE INJECTION? 1. Weight Gain You may experience a weight gain while you are using DEPO-PROVERA. About two thirds of the women who used DEPO-PROVERA in clinical trials reported a weight gain of about 5 pounds during the first year of use. You may continue to gain weight after the first year. Women in one large study who used DEPO-PROVERA for 2 years gained an average total of 8.1 pounds over those 2 years, or approximately 4 pounds per year. Women who contin- ued for 4 years gained an average total of 13.8 pounds over those 4 years, or approximate- ly 3.5 pounds per year. Women who continued for 6 years gained an average total of 16.5 pounds over those 6 years, or approximately 2.75 pounds per year. 2. Other Side Effects In a clinical study of over,3,900 women who used DEPO-PROVERA for up to 7 years, some women reported the following effects that may or may not have been related to their use of DEPO-PROVERA: Irregular menstrual bleeding, amenorrhea, headache, nervousness, abdominal cramps, dizziness, weakness or fatigue, decreased sexual desire, leg cramps, nausea, vaginal discharge or irritation, breast swelling and tendemess, bloating, swelling of the hands or feet, backache, depression, insomnia, acne, pelvic pain, no hair growth or excessive hair loss, rash, and hot flashes. Other problems were reported by very few of the women in the clinical trials, but some of these could be serious. These include convulsions, jaundice, urinary tract infections, allergic reactions, fainting, paralysis, osteoporosis, lack of return to fertility, deep vein thrombosis, pulmonary embolus, breast cancer, or cervical can- cer. If these or any other problems occur during your use of DEPO-PROVERA, discuss them with your health-care provider. SHOULD ANY PRECAUTIONS BE FOLLOWED DURING USE OF DEPO-PROVERA CONTRACEPTIVE INJECTION? 1. Missed Periods During the time you are using DEPO-PROVERA for contraception, you may skip a period, or your periods may stop completely. If you have been receiving your DEPO-PROVERA injections regularly every 3 months, then you are probably not pregnant. However, if you think that you may be pregnant, see your health-care provider. 2. Laboratory Test Interactions If you are scheduled for any laboratory tests, tell your health-care provider that you are using DEPO-PROVERA for contraception. Certain blood tests are affected by hormones such as DEPO-PROVERA. 3. Drug Interactions Cytadren (aminoglutethimide) is an anticancer drug that may significantly decrease the effectiveness of DEPO-PROVERA if the two drugs are given during the same time. rq W 0 0 MOSCOW ST. PETERSBURG MOSCOW I would like to receive more information on your Moscow Internship Program. I am interested in a semester.. .-or a summer- Moscow Internship Program. Name Street City Phone ( State College or University Current Status: 0 Fr Zip Q So 0 Jr 0 Sr If you prefer, call 617/353-9888. R Y I 0l WHO SHOULD NOT USE DEPO-PROVERA CONTRACEPTIVE INJECTION? Not all women should use DEPO-PROVERA. You should not use DEPO-PROVERA if you think you might be pregnant, have any vaginal bleeding without a known reason, have had cancer of the breast, have had a stroke, have or have had blood clots (phlebitis) in your legs, have problems with your liver or liver disease, or are allergic to DEPO- PROVERA (medroxyprogesterone acetate or any of its other ingredients). You will have a physical examination before your doctor prescribes DEPO-PROVERA. It is important to tell your doctor if you are taking any prescription or over-the-counter medications or if you have a family history of breast cancer; an abnormal mammogram (breast x-ray), fibrocystic breast disease, breast nodules or lumps, or bleeding from your nipples; kidney disease; irregular or scanty menstrual periods; high blood pressure; migraine headaches; asthma; epilepsy (convulsions or seizures); diabetes or a family history of diabetes; or a history of depression. I I